Source: Manufacturing Chemist

Idifarma: Idifarma launches accelerated pathway service for drug development

The service also aims to maximise yield and minimise waste of API and aims for a quick, reliable, on time and in full delivery of batches

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

General Manager

Luis Oquinena

CEO Approval Rating

89/100

Read more